International Cancer Imaging Society

Our Journal - Cancer Imaging

Our Journal 1

We are pleased to announce that as from 1st January 2014 Cancer Imaging will be published by BioMed Central, thereby enhanced with the full benefits of open access.

Our Journal 1

Cancer Imaging is the official journal of ICIS, and is now an open access, peer-reviewed journal published by BioMed Central. Original articles, as well as reviews and editorials written by international imaging experts with a subspecialty focus on oncology, are published regularly online;  sign up for alerts to keep up-to-date with the latest articles.  Alongside the 2013 impact factor of 1.29, Cancer Imaging is pleased to announce the 5-year impact factor of 1.76, enhanced by a very favourable Immediacy Index score.  

The journal encompasses CT, MRI, ultrasound, single photon and positron emission tomography, including multimodality imaging in all kinds of malignant tumours, plus new developments, techniques and innovations.

All articles published in Cancer Imaging are included in PubMed, the most widely used biomedical bibliographic database service, as well as Embase, EmCare, Google Scholar, MEDLINE, Science Citation Index and Scopus. The full text of all research articles is deposited in PubMed Central, the US National Library of Medicine's full-text repository of life science literature.

Submit your next manuscript to Cancer Imaging and take full advantage of the following:

Our Journal 4

Members Area

Cancer / Oncology News From Medical News Today

New drug could help in battle against cervical cancer

Published: Fri, 24 Oct 2014 09:00:00 GMT

In Europe patients with recurrent or secondary cancer have a low chance of survival, with only 20-30% experiencing tumour shrinkage after conventional chemotherapy and life expectancy being...

Cancer drug discovery system is broken, global summit hears

Published: Fri, 24 Oct 2014 09:00:00 GMT

The global system for discovering new cancer drugs is 'broken', and failing to turn dramatic scientific advances into enough innovative, game-changing medicines, a world-leading UK expert has...

The quality of biopsy is directly linked to survival in patients with bladder cancer

Published: Thu, 23 Oct 2014 09:00:00 GMT

UCLA researchers have shown for the first time that the quality of diagnostic staging using biopsy in patients with bladder cancer is directly linked with survival, meaning those that don't get...

Research reveals how lymph nodes expand during disease

Published: Thu, 23 Oct 2014 09:00:00 GMT

Cancer Research UK and UCL scientists have discovered that the same specialised immune cells that patrol the body and spot infections also trigger the expansion of immune organs called lymph nodes...

'Designer' nanodevice could improve treatment options for cancer sufferers

Published: Thu, 23 Oct 2014 09:00:00 GMT

Cancer diagnostics and treatment options could be drastically improved with the creation of a 'designer' nanodevice being developed by researchers from the UK, Italy, the US and Argentina.

Doctors boost fitness of cancer patients using novel 'prehab' programme

Published: Thu, 23 Oct 2014 09:00:00 GMT

Doctors in Southampton can return cancer patients to pre-treatment fitness levels within six weeks using a novel 'prehabilitation' programme.

Genomic sequencing: could it aid breast cancer prevention?

Published: Thu, 23 Oct 2014 07:00:00 GMT

A new study by researchers from the Stanford Cancer Institute finds genomic sequencing may be more helpful in identifying a woman's risk for breast cancer than previously estimated

When heart cancer hides in the brain: how a lucky coincidence led to rare diagnosis

Published: Wed, 22 Oct 2014 17:00:00 GMT

It was fortunate for the middle-aged woman that she presented her symptoms at the European Institute of Oncology (IEO), where doctors had seen another strange case just two years before.

Knowing individual risk does not increase cancer screening rates

Published: Wed, 22 Oct 2014 09:00:00 GMT

Knowing their individual risk for disease is not enough to pursuade previously nonadherent patients to undergo recommended colorectal cancer (CRC) screenings, according to a randomized, controlled...

Clinical trial demonstrates prolonged survival for advanced multiple myeloma patients

Published: Wed, 22 Oct 2014 09:00:00 GMT

John Theurer Cancer Center at Hackensack University Medical Center has announced publication of breakthrough data in the treatment of advanced multiple myeloma in the journal Biology of Blood and...

Subscribe to our mailing list

* indicates required
Email Format


Radiologist Jelle Barentsz Knighted

Radiologist Jelle Barentsz Knighted

Published: Fri, 30 May 2014

Based on international and national recommendations and evaluation letters of ...

» More News